March 1, 2016 (GLOBE NEWSWIRE) — Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical device company specializing in foot and ankle products, announced today that the company’s Lync Hammertoe Implant has been successfully used in more than 2,000 surgical cases.
The Lync Hammertoe System features a one-piece implant that is manufactured from pure titanium. Its design is patent pending and includes insertion tapers and migration resistant talons that allow for accurate placement and stable bone purchase. The reported outcomes of this next generation product for hammertoe deformity correction, which is differentiated from its competitors in both design and material, have impressed members of the foot and ankle surgical community.
Roman Sibel, MD of Orthopedic Foot & Ankle Institute in Las Vegas, Nevada, who specializes in trauma and reconstructive surgery, explained that “The Lync System is efficient, reliable and effective. The implant can be used at ambient temperatures because it does not require refrigeration and its platform consists of only three instruments that are neatly organized into one minimally sized sterilization module. Medullary canal preparation and device insertion do not require the placement of guidewires and the actual surgery is performed in four, easily reproducible steps.”
The Lync is available in two angular offsets, straight or with a 10⁰ bend, for precise anatomic fitting and alignment. Loïc Girod, Novastep’s Vice President of Research and Development added that “The entire system was engineered with the surgeon and O.R. staff in mind. Our objective was to save everyone time and effort. This philosophy inspired us to come up with a streamlined set of instruments that includes the multi-purpose insertion forceps which highlight a uniquely designed lock and load capability, permitting convenient implant deployment, rapid insertion and manual, one-click compression. The implant’s proximal and distal leg pairs are designed to spring into simultaneous action by means of these forceps to impart bifocal intramedullary compressive forces for enhanced stability and resistance to pullout.”
All Novastep implants, including the Lync, are packaged sterile and are neatly arranged by means of the cleanSTART Dispenser. The Lync implants are individually packaged in quickTUBE cylinders that permit simplified inventory control and reliable tracking.
Lync, along with other ingredients of the Novastep portfolio will be featured this week during the American Academy of Orthopaedic Surgeons (AAOS) in Orlando, FL at Booth No. 3523
Novastep is a global medical device company specializing in the design, development and commercialization of advanced technologies that treat conditions affecting the foot and ankle. The Company is focused to optimize clinical efficiencies, inventory management and healthcare economics by transforming the way foot and ankle products are deployed and utilized in the surgical environment. Novastep has allied itself with a strategic network of key international opinion leaders to deliver breakthrough technologies, innovative services and compelling medical education programs to the foot and ankle community.
Novastep’s portfolio, services and distribution platforms are uniquely positioned to address foot and ankle pathologies, including trauma, deformity corrections and Charcot fracture management. Follow Novastep live on Twitter @InfoNovastep.
For further information concerning this announcement and/or Novastep, Inc., send all inquiries to email@example.com or call 877.287.0795.